wellbutrin sr

Generic: bupropion hydrochloride

Labeler: glaxosmithkline llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name wellbutrin sr
Generic Name bupropion hydrochloride
Labeler glaxosmithkline llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
GlaxoSmithKline LLC

Identifiers & Regulatory

Product NDC 0173-0135
Product ID 0173-0135_d1f06b35-e63d-49dc-a05d-9546f61776aa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020358
Listing Expiration 2026-12-31
Marketing Start 1996-11-15

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01730135
Hyphenated Format 0173-0135

Supplemental Identifiers

RxCUI
993503 993511 993518 993528 993536 993537
UPC
0301730722003 0301730135551 0301730947550
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name wellbutrin sr (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number NDA020358 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET, FILM COATED in 1 BOTTLE (0173-0135-55)
source: ndc

Packages (1)

0173-0135-55 60 TABLET, FILM COATED in 1 BOTTLE (0173-0135-55)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

WELLBUTRIN SR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d1f06b35-e63d-49dc-a05d-9546f61776aa", "openfda": {"upc": ["0301730722003", "0301730135551", "0301730947550"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993511", "993518", "993528", "993536", "993537"], "spl_set_id": ["cbc8c074-f080-4489-a5ae-207b5fadeba3"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (0173-0135-55)", "package_ndc": "0173-0135-55", "marketing_start_date": "19961115"}], "brand_name": "WELLBUTRIN SR", "product_id": "0173-0135_d1f06b35-e63d-49dc-a05d-9546f61776aa", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0173-0135", "generic_name": "bupropion hydrochloride", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "WELLBUTRIN", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "NDA020358", "marketing_category": "NDA", "marketing_start_date": "19961115", "listing_expiration_date": "20261231"}